European urology最新文献

筛选
英文 中文
How Sound Are High-intensity Focused Ultrasound Data? 高强度聚焦超声数据有多好?
IF 23.4 1区 医学
European urology Pub Date : 2025-01-06 DOI: 10.1016/j.eururo.2024.12.013
Nikos Grivas, Daniel Eberli, Henk van der Poel
{"title":"How Sound Are High-intensity Focused Ultrasound Data?","authors":"Nikos Grivas, Daniel Eberli, Henk van der Poel","doi":"10.1016/j.eururo.2024.12.013","DOIUrl":"https://doi.org/10.1016/j.eururo.2024.12.013","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"15 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142935111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.11.003 回复Jonas Hugosson。基于人群的前列腺癌筛查:是时候了吗?Urol欧元。在出版社。https://doi.org/10.1016/j.eururo.2024.11.003
IF 23.4 1区 医学
European urology Pub Date : 2025-01-04 DOI: 10.1016/j.eururo.2024.12.012
Renée C.A. Leenen, Monique J. Roobol, Katharina Beyer
{"title":"Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.11.003","authors":"Renée C.A. Leenen, Monique J. Roobol, Katharina Beyer","doi":"10.1016/j.eururo.2024.12.012","DOIUrl":"https://doi.org/10.1016/j.eururo.2024.12.012","url":null,"abstract":"No Abstract","PeriodicalId":12223,"journal":{"name":"European urology","volume":"18 1 1","pages":""},"PeriodicalIF":23.4,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142925244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial” [Eur. Urol. 86(2) (2024) 90–94] Cabozantinib加Nivolumab治疗非透明细胞肾细胞癌患者:II期试验的最新结果》更正 [Eur. Urol. 86(2) (2024) 90-94]
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.10.002
Kelly N. Fitzgerald , Chung-Han Lee , Martin H. Voss , Maria I. Carlo , Andrea Knezevic , Laura Peralta , Yingbei Chen , Robert A. Lefkowitz , Neil J. Shah , Colette N. Owens , Deaglan J. McHugh , David H. Aggen , Andrew L. Laccetti , Ritesh R. Kotecha , Darren R. Feldman , Robert J. Motzer
{"title":"Corrigendum to “Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial” [Eur. Urol. 86(2) (2024) 90–94]","authors":"Kelly N. Fitzgerald , Chung-Han Lee , Martin H. Voss , Maria I. Carlo , Andrea Knezevic , Laura Peralta , Yingbei Chen , Robert A. Lefkowitz , Neil J. Shah , Colette N. Owens , Deaglan J. McHugh , David H. Aggen , Andrew L. Laccetti , Ritesh R. Kotecha , Darren R. Feldman , Robert J. Motzer","doi":"10.1016/j.eururo.2024.10.002","DOIUrl":"10.1016/j.eururo.2024.10.002","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Page 96"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142449845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)” [Eur Urol. 86(1) (2024) 52–60] 前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描对前列腺癌挽救性放疗管理的影响:一项前瞻性多中心随机3期试验(PSMA-SRT NCT03582774)的结果"[欧洲泌尿外科杂志》(Eur Urol.
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.10.022
Wesley R. Armstrong , Amar U. Kishan , Kiara M. Booker , Tristan R. Grogan , David Elashoff , Ethan C. Lam , Kevyn J. Clark , Michael L. Steinberg , Wolfgang P. Fendler , Thomas A. Hope , Nicholas G. Nickols , Johannes Czernin , Jeremie Calais
{"title":"Corrigendum to “Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)” [Eur Urol. 86(1) (2024) 52–60]","authors":"Wesley R. Armstrong , Amar U. Kishan , Kiara M. Booker , Tristan R. Grogan , David Elashoff , Ethan C. Lam , Kevyn J. Clark , Michael L. Steinberg , Wolfgang P. Fendler , Thomas A. Hope , Nicholas G. Nickols , Johannes Czernin , Jeremie Calais","doi":"10.1016/j.eururo.2024.10.022","DOIUrl":"10.1016/j.eururo.2024.10.022","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Pages 97-99"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142597140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer 关于前列腺切除术、近距离放射治疗、体外放射治疗、激素治疗或局部前列腺癌监测后的长期前列腺癌特异性死亡率。
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.07.009
Francesco Montorsi , Mattia Longoni , Alberto Briganti , Giorgio Gandaglia
{"title":"Re: Long-term Prostate Cancer–specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer","authors":"Francesco Montorsi , Mattia Longoni , Alberto Briganti , Giorgio Gandaglia","doi":"10.1016/j.eururo.2024.07.009","DOIUrl":"10.1016/j.eururo.2024.07.009","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Pages 93-94"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories 针对晚期疾病状态的前列腺癌治疗心脏毒性图谱(PROXMAP):采用贝叶斯治疗历史建模的系统综述和网络 Meta 分析。
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.08.031
Moez Karim Aziz , Donald Molony , Dominique Monlezun , Travis Holder , Oliver Brunckhorst , Noel Higgason , Jerry Roland , Resa Magill , Mariya Fatakdawala , Alexander Iacobucci , Neal Mody-Bailey , Chris Owen , Andrew Zarker , Emma Thames , Justin Swaby , Daniel Xiao , Lily Choi , Shubh Desai , Jacob Galan , Brett Deng , Steven Canfield
{"title":"Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories","authors":"Moez Karim Aziz ,&nbsp;Donald Molony ,&nbsp;Dominique Monlezun ,&nbsp;Travis Holder ,&nbsp;Oliver Brunckhorst ,&nbsp;Noel Higgason ,&nbsp;Jerry Roland ,&nbsp;Resa Magill ,&nbsp;Mariya Fatakdawala ,&nbsp;Alexander Iacobucci ,&nbsp;Neal Mody-Bailey ,&nbsp;Chris Owen ,&nbsp;Andrew Zarker ,&nbsp;Emma Thames ,&nbsp;Justin Swaby ,&nbsp;Daniel Xiao ,&nbsp;Lily Choi ,&nbsp;Shubh Desai ,&nbsp;Jacob Galan ,&nbsp;Brett Deng ,&nbsp;Steven Canfield","doi":"10.1016/j.eururo.2024.08.031","DOIUrl":"10.1016/j.eururo.2024.08.031","url":null,"abstract":"<div><h3>Background and objective</h3><div>Recommendations of first-line therapies for metastatic hormone-sensitive (mHSPC), nonmetastatic castrate-resistant (M0CRPC), and metastatic castrate-resistant (mCRPC) prostate cancer do not account for cardiotoxicity due to a lack of clear prior evidence. This manuscript assesses cardiotoxicity of these therapies.</div></div><div><h3>Methods</h3><div>We searched Ovid Medline, Elsevier Embase, and the Cochrane Library for randomized clinical trials (RCTs) from database inception to January 14, 2024. Network meta-analyses of first-line mHSPC, M0CRPC, and mCRPC therapies were constructed for the five cardiotoxicity metrics defined by the International Cardio-Oncology Society: heart failure, myocarditis, vascular toxicity, hypertension, and arrhythmias. Additional Bayesian network meta-analyses also accounted for prior treatment history.</div></div><div><h3>Key findings and limitations</h3><div>Thirteen RCTs (16 292 patients) were included. For mHSPC, androgen deprivation therapy (ADT) plus docetaxel (DTX) plus abiraterone acetate (AA) with prednisone (P) demonstrated a significant increase in hypertension and arrhythmias versus ADT + DTX (risk ratio [RR] 2.85, 95% confidence interval [CI] 1.67–4.89, and RR 2.01, 95% CI 1.17–3.44, respectively); however, no corresponding differences were observed between ADT + DTX plus darolutamide (DAR) and ADT + DTX (RR 1.55, 95% CI 0.73–3.30, and RR 0.94, 95% CI 0.63–1.40, respectively). For mCRPC assuming a history of mHSPC treatment, ADT + AA + P plus olaparib (OLA) demonstrated a statistically significant decrease in hypertension versus ADT + AA + P (RR 0.20, 95% CI 0.16–0.26). M0CRPC results were unremarkable.</div></div><div><h3>Conclusions and clinical implications</h3><div>For mHSPC, ADT + DTX + DAR demonstrates less cardiotoxicity than ADT + DTX + AA + P due to a lower risk of hypertension and arrhythmias from decreased mineralocorticoid excess. In addition, OLA counterintuitively offers decreased hypertension when superimposed on ADT + AA + P for mCRPC treatment after prior androgen deprivation from mHSPC therapy.</div></div>","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Pages 15-26"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. 2025;87:388–390 关于Niklas Klümper、Viktor Grünwald、Arndt Hartmann 等:《微卫星不稳定性/DNA 错配修复缺陷和肿瘤突变负荷作为生物标志物在预测阉割耐药前列腺癌免疫疗法反应中的作用》(The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer)。欧洲泌尿外科杂志》。https://doi.org/10.1016/j.eururo.2024.04.026.
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.08.037
Feng Qi
{"title":"Re: Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al. The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer. Eur Urol. 2025;87:388–390","authors":"Feng Qi","doi":"10.1016/j.eururo.2024.08.037","DOIUrl":"10.1016/j.eururo.2024.08.037","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Pages e15-e16"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refining the Tissue Source for Biomarker-based Approaches in Renal Cell Carcinoma 为基于生物标记物的肾细胞癌方法完善组织来源。
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.09.029
Scott M. Haake, Brian I. Rini
{"title":"Refining the Tissue Source for Biomarker-based Approaches in Renal Cell Carcinoma","authors":"Scott M. Haake,&nbsp;Brian I. Rini","doi":"10.1016/j.eururo.2024.09.029","DOIUrl":"10.1016/j.eururo.2024.09.029","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Pages 84-85"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standard Repeat Biopsies During Active Surveillance for Prostate Cancer: Are They Necessary in the Magnetic Resonance Imaging Era? 前列腺癌主动监测期间的标准重复活检:在磁共振成像时代是否有必要?
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.09.014
Roderick C.N. van den Bergh , Ivo G. Schoots , Philip A. Cornford , European Association of Urology Prostate Cancer Guidelines Panel
{"title":"Standard Repeat Biopsies During Active Surveillance for Prostate Cancer: Are They Necessary in the Magnetic Resonance Imaging Era?","authors":"Roderick C.N. van den Bergh ,&nbsp;Ivo G. Schoots ,&nbsp;Philip A. Cornford ,&nbsp;European Association of Urology Prostate Cancer Guidelines Panel","doi":"10.1016/j.eururo.2024.09.014","DOIUrl":"10.1016/j.eururo.2024.09.014","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Pages 5-7"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142335145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management Decisions for Metastatic Castration-resistant Prostate Cancer in 2024 2024 年转移性抗阉割前列腺癌的管理决策
IF 25.3 1区 医学
European urology Pub Date : 2025-01-01 DOI: 10.1016/j.eururo.2024.10.003
David J. VanderWeele, Maha Hussain
{"title":"Management Decisions for Metastatic Castration-resistant Prostate Cancer in 2024","authors":"David J. VanderWeele,&nbsp;Maha Hussain","doi":"10.1016/j.eururo.2024.10.003","DOIUrl":"10.1016/j.eururo.2024.10.003","url":null,"abstract":"","PeriodicalId":12223,"journal":{"name":"European urology","volume":"87 1","pages":"Pages 47-48"},"PeriodicalIF":25.3,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142450255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信